Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations.

Department of Radiology, Neurology, Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Lake Erie College of Osteopathic Medicine, Erie, PA, USA. Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan. Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Department of Ophthalmology and Vision Sciences, Princess Margaret Hospital/University Health Network, University of Toronto, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Mostafa.hanout@gmail.com.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2019;(3):447-452
Full text from:

Abstract

Interferons are cytokines that regulate the host's response to viral infection, particularly in the setting of the immunologic response to the hepatitis C virus (HCV). While the virus has the ability to evade the host's innate and specific immunity, exogenous interferon-α with combined ribavirin, treatments have been found to achieve a significant sustained viral response in subgroups of patients with chronic HCV. One of the major side effects of interferon-α is an ocular retinopathy characterized by flame-shaped hemorrhages and cotton wool spots visualized on funduscopic examination. There have been documented cases of more severe side effects including optic nerve and retinal artery damage; however, these instances are the minority. We sought to investigate the literature surrounding interferon-induced retinopathy, clinically correlate our findings with two recent cases, and provide recommendations for practitioners who continue to manage chronic HCV patients using interferon-α with combined ribavirin treatments.

Methodological quality

Publication Type : Review

Metadata

MeSH terms : Hepatitis C, Chronic